Call for Abstract
28th European Diabetes Congress, will be organized around the theme “Recent Advancements and Developments for Changing Life of Diabetes World”
Diabetes expo europe 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetes expo europe 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes (e.g., maturity-onset diabetes of the young), the majority of genetic risk of diabetes (for type 1 and type 2) remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies. Diabetic amyotrophic is a disabling illness that is distinct from other forms of diabetic neuropathy.
- Track 1-1Type 1 Diabetes Hereditary
- Track 1-2Diet
- Track 1-3Obesity
- Track 1-4Metabolic Syndrome
- Track 1-5Insulin Resistance
- Track 1-6Measles
- Track 1-7Mumps
- Track 1-8Coxsackie B virus
- Track 1-9Rotavirus
Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned. Diabesity can be defined as a metabolic dysfunction that ranges from mild blood sugar imbalance to full-fledged type 2 diabetes. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal.
- Track 2-1Diabetes Research
- Track 2-2Diabetes and cancer
- Track 2-3Obesity
- Track 2-4Type 1 Diabetes
- Track 2-5Type 2 Diabetes
- Track 2-6Diabetic dyslipidemia
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
- Track 3-1Diabetic Cardiomyopathy
- Track 3-2Diabetic Retinopathy
- Track 3-3Prediabetes
- Track 3-4Increased thirst
- Track 3-5Frequent urination
- Track 3-6Extreme hunger
- Track 3-7Unexplained weight loss
- Track 3-8Presence of ketones in the urine Fatigue
- Track 3-9Irritability
- Track 3-10Blurred vision
- Track 3-11Slow-healing sores
- Track 3-12Frequent infections, such as gums or skin infections and vaginal infections
Type 1 Diabetes mellitus (otherwise called type 1 diabetes) is a type of diabetes mellitus that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of insulin prompts expanded glucose in the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction. The reason for diabetes mellitus sort 1 is obscure. Type 1 diabetes can be recognized from type 2 from autoantibody testing. The C-peptide test, which measures endogenous insulin generation, can likewise be utilized.
Organization of insulin is fundamental for survival. Insulin treatment must be proceeded with uncertainly and commonly does not disable ordinary every day exercises. Individuals are normally prepared to freely deal with their diabetes; be that as it may, for some this can challenge. Untreated, diabetes can bring about numerous confusions. Intense confusions incorporate diabetic ketoacidosis and nonketotic hyperosmolar trance like state. Genuine long haul complexities identified with high glucose incorporate coronary illness, stroke, kidney disappointment, foot ulcers and harm to the eyes. Moreover, confusions may emerge from low glucose brought about by exorbitant insulin treatment.
Diabetes mellitus Type 1 represents somewhere around 5% and 10% of all diabetes cases. All inclusive, the quantity of individuals with DM sort 1 is obscure, in spite of the fact that it is assessed that 80,000 kid’s build up the illness every year. Inside the United States the quantity of influenced people is assessed at one to three million. The advancement of new cases fluctuates by nation and locale: the least rates give off an impression of being in Japan and China, with around 1 individual for each 100,000 every year; the most elevated rates are found in Scandinavia, where rates are more like 35 new cases for each 100,000 every year. The United States and different nations in northern Europe fall some place in the middle of, with 8-17 new cases for every 100,000 every year.
- Track 4-1A1C test
- Track 4-2Blood pressure test
- Track 4-3Pancreas Transplant Animation
- Track 4-4Fatigue
- Track 4-5Frequent Urination
- Track 4-6Sisters’ Bone Marrow Transplant
- Track 4-7Stem cell transplant
- Track 4-8Urinalysis
- Track 4-9Polyuria
- Track 4-10Polydipsia
- Track 4-11Polyphagia
Type 2 diabetes is a long haul metabolic turmoil that is portrayed by high glucose, insulin resistance, and relative absence of insulin. Basic side effects incorporate expanded thirst, incessant pee, and unexplained weight reduction. Indications may likewise incorporate expanded craving, feeling tired, and bruises that don't recuperate. Regularly indications go ahead gradually. Long haul complexities from high glucose incorporate coronary illness, strokes, diabetic retinopathy which can bring about visual impairment, kidney disappointment, and poor blood stream in the appendages which may prompt removals. The sudden onset of hyperosmolar hyperglycaemic state may happen; in any case, ketoacidosis is unprecedented. Type 2 diabetes is mostly preventable by staying a typical weight, practicing consistently, and eating legitimately. Treatment includes activity and dietary changes. In the event that glucose levels are not sufficiently brought down, the medicine metformin is regularly suggested. Numerous individuals may in the end likewise require insulin infusions. In that on insulin, routinely check glucose levels is exhorted, in any case this may not be required in those taking pills. Bariatric surgery frequently enhances diabetes in the individuals who are stout.
Rates of type 2 diabetes have expanded uniquely since 1960 in parallel with corpulence. Starting 2013 there were roughly 368 million individuals determined to have the illness contrasted with around 30 million in 1985. Typically it starts in centre or more seasoned age, although rates of type 2 diabetes are expanding in youngsters. Type 2 diabetes is connected with a ten-year-shorter future. Diabetes was one of the primary maladies depicted. The significance of insulin in the malady was resolved in the 1920s.
- Track 5-1Glucose tolerance test
- Track 5-2Unexplained weight loss
- Track 5-3Heart and blood vessel disease
- Track 5-4Nerve damage (neuropathy)
- Track 5-5Kidney damage (nephropathy)
- Track 5-6Hearing impairment
- Track 5-7Alzheimers disease
Gestational diabetes is first analysed amid pregnancy. Like type 1 and type 2 diabetes, gestational diabetes causes glucose levels to wind up noticeably too high. When you eat, your stomach related framework separates the greater part of the sustenance into a sugar called glucose. It's the point at which the blood glucose level (glucose level) of the mother goes too high amid pregnancy. Gestational diabetes creates when your body can't deliver enough of the hormone insulin amid pregnancy. Insulin is important to transport glucose what your body utilizes for vitality into the cells. Without enough insulin, you can develop excessively glucose in your blood, prompting a higher-than-typical blood glucose level and maybe gestational diabetes. The higher blood glucose level in gestational diabetes caused by hormones discharged by the placenta amid pregnancy. The placenta delivers a hormone called the human placental lactogen (HPL), otherwise called human chorionic somatomammotropic (HCS). It's like development hormone (so it enables the infant to develop), yet it really alters the mother's digestion and how she forms sugars and lipids. HPL really raises the mother's blood glucose level and makes her body less delicate to insulin—less ready to utilize it appropriately. In the event that the body doesn't utilize insulin as it should, the blood glucose level goes up. The HPL hormone lifts the blood glucose level with the goal that the child gets enough supplements from the additional glucose in the blood.
- Track 6-1Genetics of Diabetes
- Track 6-2Placental Hormones
- Track 6-3Blurred Vision
- Track 6-4Fatigue
- Track 6-5Diet Therapy
- Track 6-6Insulin Therapy
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in adults in the U.S. It is caused by changes in the blood vessels of the retina. The retina is the light-sensitive tissue at the back of the eye. A healthy retina is necessary for good vision. Diabetic retinopathy can be detected during a dilated eye exam by an ophthalmologist or optometrist. An exam by your primary doctor, during which your eyes are not dilated, is not an adequate substitute for a full exam done by an ophthalmologist. Eye exams for people with diabetes can include: Visual acuity testing. Diabetic retinopathy affects blood vessels in the light-sensitive tissue called the retina that lines the back of the eye. It is the most common cause of vision loss among people with diabetes and the leading cause of vision impairment and blindness among working-age adults.
Diabetes can harm your eyes. It can damage the small blood vessels in your retina, or the back of your eye. This condition is called diabetic retinopathy. Diabetes also increases your risk of glaucoma and other eye problems. There is no cure for diabetic retinopathy. But laser treatment (photocoagulation) is usually very effective at preventing vision loss if it is done before the retina has been severely damaged. Surgical removal of the vitreous gel (vitrectomy) may also help improve vision if the retina has not been severely damaged.
- Track 7-1Ophthalmic Investigations
- Track 7-2No proliferative and Proliferative retinopathy
- Track 7-3Diabetic Macular Edema (DME)
- Track 7-4Vitrectomy surgery
- Track 7-5Cataract and Glaucoma
- Track 7-6Laser Treatment of Diabetic Retinopathy
- Track 7-7Special Treatments- Scatter photocoagulation, focal photocoagulation
The risk of CVD mortality in type 2 diabetic patients is more than double compared with that in age-matched subjects. Stroke events and all manifestations of CHD, myocardial infarction (MI), sudden death, and angina pectoris is at least twofold more common in patients with type 2 diabetes than in non-diabetic individuals. A high proportion of patients with type 2 diabetes die after an acute MI within 1 year, and a considerable number of patients die outside the hospital. Relative risk for CHD events is higher in female patients with type 2 diabetes than in male patients with type 2 diabetes. The reason for the sex difference is largely unknown but could be at least in part explained by a heavier risk-factor burden and a greater effect of blood pressure and atherogenic dyslipidemia on the risk of CVD in diabetic women than in diabetic men.
The prognosis of patients with type 2 diabetes is highly dependent on the presence of CVD. We compared the 7-year incidence of fatal and nonfatal MI among 1,373 non-diabetic subjects with the incidence among 1,059 subjects with type 2 diabetes. Our study suggested that patients with type 2 diabetes without previous MI have as high a risk of MI as non-diabetic patients with previous MI. Thus, our results indicated that type 2 diabetes is a “coronary heart disease equivalent.” These results were recently replicated by an 18-year follow-up study of our original cohort and by a Danish study including 3.3 million subjects. One of the paradoxes in the studies of cardiovascular complications in type 2 diabetes is that at diagnosis individuals with type 2 diabetes already has substantially increased prevalence of CHD and stroke.
- Track 8-1High Blood Pressure
- Track 8-2Heart Disease
- Track 8-3High Blood Glucose
- Track 8-4Damage of Blood Vessels
- Track 8-5Atherosclerosis and Hypertension
- Track 8-6Shortness of Breath
- Track 8-7Diabetic Neuropathy
In every of these cases, using one's own stem cells will facilitate the exocrine gland regenerate and boost its ability to produce insulin. Procedure continues to achieve success, with patients experiencing health advantages even six months after stem cell diabetes treatment. repeated applications of adipose stem cells is that the most effective treatment for diabetes type two, providing an open window to create dietary changes, supplementation and exercise much more effective for long-term management of blood glucose. Adult stem cells, undifferentiated and adaptable, area unit ready to transform into the cells of innumerable organs and structures inside the body. Several therapies use stem cells as they will restore broken structures and rejuvenate failing cells very effectively. Stem cell science has seen considerable advancements within the previous few years with several new developments and discoveries being created.
Swiss Medica Clinic has developed the Adult autologous stem cell medical care program to treat a range of conditions. Throughout stem cell treatment a patient receives 200 – 300 million stem cells. The number of restored cells not only covers daily losses, however exceeds them 1000 times. Thus, the reserve of the stem cells, much lost for the newest 15 – 20 years, is restored. When such active cell filling, organ gets rejuvenated and revived, because the new and active cells displace the previous and broken ones
- Track 9-1Stem Cell Therapy
- Track 9-2Treatment of Diabetes
- Track 9-3Embryonic Stem Cell Research
- Track 9-4Type 1 Diabetes Beta Cells
- Track 9-5Umbilical Stem Cells
- Track 9-6Stem Cells and Diabetes
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc.) come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
- Track 10-1New Discoveries and Emerging Therapies for Type 1 Diabetes
- Track 10-2New Discovery and Treatment for Type 2 Diabetes
- Track 10-3New Therapeutic Mechanisms for Diabetes
- Track 10-4Other advanced medical technologies used in hospitals
- Track 10-5Exploring novel therapies in diabetes treatment
Insulin medical care is usually recommended for patients with kind a pair of diabetes associate degreed an initial A1C level bigger than 9 %, or if diabetes is uncontrolled despite optimum oral glycaemic medical care. Internal secretion medical care is also initiated as augmentation, beginning at 0.3 units per weight unit, or as replacement, beginning at 0.6 to 1.0 units per weight unit. Aldohexose management, adverse effects, cost, adherence, and quality of life have to be compelled to be thought of once selecting medical care. Anti- diabetic drug ought to be continued if potential as a result of its verified to scale back all-cause mortality and vessel events in overweight patients with diabetes diseases. Volumetric analysis of internal secretion over time is important to up glycaemic management and preventing diabetes-related complications.
- Track 11-1Diabetes and Insulin
- Track 11-2Insulin Medication of Type 2 Diabetes Mellitus
- Track 11-3Insulin Therapy
- Track 11-4Insulin with Oral Medications
- Track 11-5Insulin Injection Technique
- Track 11-6Types of insulin treat diabetes
- Track 11-7Postprandial Hyperglycemia
A Ketogenic diet may be a very low-carb diet, considered to be once you eat a level of sugar of around 30g of carbohydrates per day or below. This encourages the body to induce its energy from burning body fat that produces AN energy supply called ketones. The diet helps to lower the body's demand for hypoglycemic agent that has advantages for individuals with type one and type two diabetes. Note that it's necessary that you just speak to your doctor if you're considering following the diet as precautions might have to be taken before beginning. On a Ketogenic diet, blood sugar levels area unit unbroken at a low however healthy level which encourages the body to interrupt down fat into a fuel supply called ketones. The method of breaking down or ‘burning’ body fat is known as ketosis. People on hypoglycemic agent can generally need smaller doses of hypoglycemic agent that results in less risk of huge dosing errors. The diet helps burn body fat and therefore, has specific benefits for those trying to reduce weight, as well as people with prediabetes, or those otherwise, in danger of type 2 diabetes.
- Track 12-1Very-low-carb Ketogenic diet (VLCKD)
- Track 12-2Well Formulated Ketogenic Diet (WFKD)
- Track 12-3MCT Ketogenic Diet
- Track 12-4Carbohydrates and diabetes
- Track 12-5Acid-alkaline diet
- Track 12-6Gluten free diet
- Track 12-7Low calorie diet
- Track 12-8Low carb diet
- Track 12-9Low fat diet
- Track 12-10Meal replacement diet plans
Endocrinology is a perplexing investigation of the different hormones and their activities and disarranges in the body. Endocrine Glands are organs that make hormones. These are substances that control exercises in the body and effectively affect the digestion system, multiplication, nourishment retention and use, development and improvement and so on. Hormones likewise control the way a living being reacts to their environment and help by giving sufficient vitality to different capacities. Diabetes is brought about by diminished creation of insulin or by diminished capacity to utilize insulin. Insulin, the hormone delivered by the beta cells in the pancreas, permits (glucose) cells to have the capacity to utilize glucose. This hormone is fundamental for glucose to go from the blood to within the body cells. With deficient insulin, glucose develops in the circulatory system as opposed to going into the cells. The body can't utilize glucose for vitality in spite of the elevated amounts of glucose in the circulatory system. This causes the unreasonable thirst, pee, and appetite, which are the most widely recognized side effects of diabetes. The abundance sugar stays in the blood and is then evacuated by the kidneys. This sickness happens in a few structures, yet the most well-known are Type I Diabetes or Juvenile Onset Diabetes or Insulin-Dependent Diabetes Mellitus (IDDM), Type II or Non-Insulin Dependent Diabetes Mellitus (NIDDM), and Gestational.
- Track 13-1Congenital adrenal hyperplasia (CAH)
- Track 13-2Graves disease
- Track 13-3Hypoglycaemia
- Track 13-4Hyperthyroidism
- Track 13-5Hypothyroidism
- Track 13-6Osteoporosis
- Track 13-7Pagets disease and Rickets
- Track 13-8Polycystic ovary syndrome (PCOS)
- Track 13-9Gestational Diabetes (Diabetes During Pregnancy)
- Track 13-10Prediabetes